financetom
Business
financetom
/
Business
/
BAT profit beats forecasts but target for smoking alternatives in doubt
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BAT profit beats forecasts but target for smoking alternatives in doubt
Jul 25, 2024 12:44 AM

LONDON, July 25 (Reuters) - British American Tobacco ( BTI )

reported a 1.3% rise in half-year profit on

Thursday, exceeding analyst expectations, but said it was likely

to fall short of its 2025 ambitions on smoking alternatives.

While BAT is looking to grow its revenue from smoking

alternatives, it still makes most of its money from tobacco. But

in the United States, a key market for all of its products,

under-pressure consumers have been swapping from its more

expensive cigarette brands to cheaper alternatives or vapes.

The maker of Dunhill and Lucky Strike cigarettes says a

flood of illegal disposable vapes is also weighing on both its

tobacco and vaping business in the United States.

Chief Executive Tadeu Marroco said that investments during

its first half were helping BAT to recover U.S. market share,

but its business and consumers remain under pressure.

"I don't expect any major shift happening in 2024," he said

of U.S. consumer behaviour in a difficult economy, adding that a

cut to interest rates is needed to lift sentiment.

The company is unlikely to meet its ambition to raise 5

billion pounds ($6.44 billion) in revenue from smoking

alternatives by 2025 given the United States is a key growth

driver, he said.

Investors view BAT's ability to transition its business away

from cigarettes towards alternative nicotine products such as

vapes as critical in the face of ever-stricter regulation and

growing awareness of health risks that are driving falling

smoking rates in some markets.

Rival Philip Morris International ( PM ) is more advanced

with such efforts. It raised its profit forecast on Tuesday,

based partly on expected growth in its alternative products.

BAT posted adjusted diluted earnings for the six months to

June 30 of 169.3 pence per share, against analyst expectations

of 165.91 pence.

Organic revenue and organic adjusted operating profit fell

0.8% and 0.9% respectively. BAT had already flagged low

single-digit declines.

The company reiterated that it expects an improved

performance in the second half, leading to low single-digit

revenue and profit growth over the full year.

($1 = 0.7765 pounds)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copart Insider Sold Shares Worth $18,210,775, According to a Recent SEC Filing
Copart Insider Sold Shares Worth $18,210,775, According to a Recent SEC Filing
Jan 7, 2025
05:42 PM EST, 01/07/2025 (MT Newswires) -- Daniel J Englander, Director, on January 03, 2025, sold 320,000 shares in Copart ( CPRT ) for $18,210,775. SEC Filing: https://www.sec.gov/Archives/edgar/data/900075/000162828025000778/xslF345X05/wk-form4_1736289556.xml ...
Exxon Mobil Sees Q4 Upstream Earnings Falling From Q3
Exxon Mobil Sees Q4 Upstream Earnings Falling From Q3
Jan 7, 2025
05:42 PM EST, 01/07/2025 (MT Newswires) -- Exxon Mobil ( XOM ) indicated changes in oil prices may reduce Q4 upstream earnings by $500 million to $900 million from Q3. Upstream earnings in Q3 were $6.2 billion, the company said Tuesday in a regulatory filing. Other factors may affect Q4 results with the final results varying from estimates, the company...
Sight Sciences Reports Positive OMNI Surgical System Data From 36-Month Study
Sight Sciences Reports Positive OMNI Surgical System Data From 36-Month Study
Jan 7, 2025
05:44 PM EST, 01/07/2025 (MT Newswires) -- Sight Sciences ( SGHT ) said late Tuesday that a 36-month study evaluating the long-term effectiveness of its OMNI Surgical System in treating primary open-angle glaucoma demonstrated sustained reductions in intraocular pressure and medication use. Mean intraocular pressure reductions ranged from 5.6 mmHg to 7.1 mmHg with greater declines in patients with higher...
BRIEF-Shutterstock Says If Merger Agreement Is Terminated, Getty Images Will Be Required To Pay Termination Fee Of $40 Million
BRIEF-Shutterstock Says If Merger Agreement Is Terminated, Getty Images Will Be Required To Pay Termination Fee Of $40 Million
Jan 7, 2025
Jan 7 (Reuters) - Shutterstock Inc ( SSTK ): * SHUTTERSTOCK INC ( SSTK ) -IF MERGER AGREEMENT IS TERMINATED, GETTY IMAGES WILL BE REQUIRED TO PAY SHUTTERSTOCK A TERMINATION FEE OF $40 MILLION * SHUTTERSTOCK INC ( SSTK ): IF MERGER AGREEMENT IS TERMINATED, CO WILL BE REQUIRED TO PAY GETTY IMAGES TERMINATION FEE IN AMOUNT OF $32.7 MILLION...
Copyright 2023-2026 - www.financetom.com All Rights Reserved